Claims about treatment results
“Is it a weight-loss drug?”
The label checked on 28 September 2026 excludes weight-loss treatment.
Body weight changed little in the main trials.
Its approved role is to reduce extra fat around the organs in adults who have HIV and lipodystrophy.
HIV is a virus; lipodystrophy is a change in where fat gathers in the body.
“Does the fat stay gone after treatment?”
In the main trials, belly fat returned during the months after people switched from tesamorelin to a dummy treatment.
Ask how that finding affects the plan for follow-up and cost.
Claims about product access and sport
“Is a pharmacy-made version the same thing?”
Under federal rules reviewed in September 2026, a pharmacy cannot lawfully make tesamorelin as a medicine to order.
Tesamorelin is in a group of medicines for which federal law does not allow pharmacy-made copies.
“Does approval settle the question for sport?”
The world sport list in force in September 2026 names tesamorelin as prohibited both during and outside competition.
An athlete who needs a prohibited medicine can apply for a medical-use exemption, meaning permission under sport’s rules.
Approval as a medicine does not provide that permission by itself.
Keep this in mind
Ask three questions about an offer: Is this the approved tesamorelin product? What condition did the studies test? What happened after people stopped treatment?